About this trial
In this study, the investigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoing therapeutic management (including surgery, chemotherapy or palliative care).
Age above 18 years old
Disqualifiers
Other malignant disease
Underlying intestinal disease that cause absorprtion disorder
Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)
Trial population
Patients who visit and treated at Samsung medical center.
Trial design
Cohort
Prospective
Treatments tested in this trial
Measurement of triceps skinfold thickness
Other interventionBy using skin thickness caliper, measure triceps skinfold thickness on the half of forearm (Rt side). In every 3 weeks, triceps skinfold thickness will be measured.
Treatment groups
Trial outcomes
Primary outcomes
Overall survival
The duration between diagnosis and death
Sponsors and contacts
Click on the lead sponsor to view all of their trials.